European Male Ageing Study (EMAS)
The EMAS aims to examine the impact of reproductive/anabolic hormones on age-related declines in physical, psychological and sexual functioning and quality of life in middle-aged and older European men. Between 2003 and 2005, the study recruited and assessed over 3,300 men, aged 40 to 79 years, from Italy, Belgium, Poland, Sweden, Spain, Hungary, and Estonia. An interim survey was conducted in 2006, and a follow-up survey was conducted from 2008 to 2010.
Study design
Cohort
Number of participants at first data collection
3,369 (participants)
Age at first data collection
40 - 79 years (participants)
Participant year of birth
Varied (participants)
Participant sex
Male
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2003
Primary Institutions
University of Manchester (Academic, United Kingdom)
Links
gbiomed.kuleuven.be/english/research/50000687/50000630/research/research-projects/all-projects/emas
doi.org/10.1111/j.1365-2605.2008.00879.x
neurodegenerationresearch.eu/cohort/the-european-male-ageing-study/
Profile paper DOI
Funders
Arthritis Research UK (now known as Versus Arthritis) (Third Sector, United Kingdom)
European Commission (Government, Europe)
National Institute for Health Research Manchester Biomedical Research Centre (Research, United Kingdom)
Ongoing?
Yes
Data types collected
- Activity log (e.g. food, sleep, exercise)
- Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
- Interview – phone
- Interview – unspecified
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- Self-completed questionnaire – paper or computer assisted
- None
- None
- Census data
- Healthcare data
- Mortality data
Engagement
Keywords
